Skip to main content
. 2023 Aug 21;16(6):943–960. doi: 10.1016/j.jcmgh.2023.08.007

Table 1.

Scoring Criteria Used by Pathologists to Assess Fibrosis and NASH Phenotype

0 1 2 3 4
Lobular fibrosis Absent Focal Multifocal Diffuse x
Bridging fibrosis Absent <34% <67% >66% Bridging
Periportal fibrosis Absent Present x x x
Inflammation 20X <2 foci 2 to 4 >4 x

NASH, Nonalcoholic steatohepatitis.